Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
Will Parsons, Interim Director at Texas Children’s Cancer and Hematology Center, shared a post on LinkedIn:
”We’re proud to recognize the national leadership roles of (pictured L-R) Drs. Titilope Fasipe, Jacquelyn “Jackie” Powers and Venee Tubman in advancing care for children with blood disorders.
• Dr. Titi Fasipe serves as Chair of the National Heart, Lung, and Blood Institute (NHLBI) Sickle Cell Disease Advisory Committee and leads two American Society of Hematology (ASH) initiatives focused on community engagement and quality care.
• Dr. Jackie Powers is Clinical Chair for ASH’s guidelines on pediatric iron deficiency, one of the few national efforts focused on children.
• Dr. Tubman leads ASH’s global guidelines on hydroxyurea dosing and monitoring, helping standardize care for children with chronic blood disorders around the world.
Please join us in celebrating their continued leadership and impact on the lives of children and families affected by blood disorders.
The NHLBI is part of the The National Institutes of Health and is focused on advancing research and education on the prevention and treatment of heart, lung, blood and sleep disorders.
ASH is the world’s largest professional organization dedicated to advancing the understanding, diagnosis, treatment and prevention of blood and bone marrow disorders through transformative research, innovative education, and high-quality, equitable care.
Texas Children’s Hospital and The University of Texas MD Anderson Cancer Center are joining forces to launch the Kinder Children’s Cancer Center in 2026.”
Learn more on this initiative here.
Stay updated on the global initiatives in the World of Hematology with Hemostasis Today.
-
Aug 14, 2025, 23:47World Thrombosis Day: Know your Risk in DVT
-
Aug 14, 2025, 12:52JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
-
Aug 14, 2025, 12:33Louise Bannon: The World Thrombosis Day Campaign is Calling on Industry Leaders
-
Aug 14, 2025, 10:58Thomas Reiser: Why October 13 Marks World Thrombosis Day?
-
Aug 14, 2025, 04:03Perioperative Thrombotic Risk Guide for Hematology Fellows
-
Aug 14, 2025, 23:47Health-related Quality of Life in Children with von Willebrand Disease
-
Aug 14, 2025, 17:54Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
-
Aug 14, 2025, 17:36Samin Mohsenian: Thrombotic Paradox in Congenital Fibrinogen Deficiencies
-
Aug 14, 2025, 17:10Emmanuel J Favaloro: DOACs and Mechanical Coagulation Test Systems
-
Aug 14, 2025, 13:09Thrombin Generation Assay to Guide Factor Therapy With Fitusiran
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot